98%
921
2 minutes
20
Rationale And Objectives: The prognostic implications of myocardial perfusion imaging (MPI) are imperative to provide proper management of coronary artery disease (CAD). This study aimed to quantify the long-term prognostic value of MPI under routine clinical conditions.
Materials And Methods: This single-center retrospective cohort study evaluated all-cause mortality and cause-specific survival according to MPI findings in patients with suspected or known CAD who underwent diagnostic evaluation or assessment of myocardial ischemia and viability in a tertiary referral cardiovascular center. A total of 2278 patients (mean age: 64.22±10.37 years; (39.2%) 893 women) were included. Kaplan-Meier analysis and Cox proportional hazards regression were used to assess outcomes and control for confounding, stratified by MPI findings. The association between coronary revascularization and survival was also assessed.
Results: During 8.17±2.17 years follow-up, 22.7% died and 16.8% received coronary revascularization (89.3±33.8 days after the index MPI). MPI severity was significantly associated with all-cause mortality (log-rank p<0.001). In multivariable Cox regression adjusting for age, gender, hypertension, diabetes, hyperlipidemia, prior myocardial infarction, body mass index, and left ventricular ejection fraction, both resting and post-stress MPI were independently associated with increased mortality risk (rest MPI: HR 1.25, 95% confidence interval (CI) 1.11-1.41, p<0.001; stress MPI: HR 1.29, 95% CI 1.15-1.45, p<0.001). Coronary revascularization was significantly associated with reduced risk of mortality (HR 0.43, 95% CI 0.32-0.57, p<0.001, in rest MPI model). The prognostic value of MPI persisted over short-, medium-, and long-term follow-up.
Conclusion: Both resting and post-stress myocardial perfusion had good long-term prognostic value for all-cause mortality. Coronary revascularization was independently associated with a reduced risk of mortality.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.acra.2025.08.046 | DOI Listing |
Hypertension
September 2025
Department of Hypertension, Center for Epidemiological Studies and Clinical Trials, the Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, China (J.W.).
Background: The association between season of screening blood pressure (BP) measurement and adverse outcomes has not been examined among populations without prior physician-diagnosed hypertension. We aimed to investigate the association between the season of screening clinic BP measurement and the risk of all-cause mortality.
Methods: This was a prospective cohort study, and data were analyzed from an ongoing community hypertension screening program in Shanghai between 2018 and 2024.
Circ Cardiovasc Interv
September 2025
Keele Cardiovascular Research Group, Keele University, United Kingdom (M.A.M., R.B.).
Background: Evidence informing clinical guidelines assumes that all transcatheter aortic valve implantation (TAVI) devices have similar effectiveness, in other words, displaying a class effect across TAVI valves. We aimed to assess the comparative effectiveness of different TAVI platforms relative to other TAVI counterparts or surgical aortic valve replacement (SAVR).
Methods: MEDLINE/Embase/CENTRAL were searched from inception until April 2025, for randomized controlled trials comparing outcomes with different commercially available TAVI devices relative to other TAVI counterparts or SAVR.
Cerebrovasc Dis Extra
August 2025
Introduction: Trousseau syndrome (TS) represents a significant vascular thromboembolic event in cancer patients and has progressively gained attention as a critical clinical concern in recent years. The aim of this study is to investigate the survival status and prognostic factors in patients with TS whose initial clinical manifestation was acute ischemic stroke (AIS).
Methods: A retrospective analysis was conducted on 24 TS patients hospitalized at the Affiliated Hospital of Jiangsu University between 2018 and 2024.
Aging Cell
September 2025
San Francisco Coordinating Center, California Pacific Medical Center Research Institute, San Francisco, California, USA.
Entropy, characterized by increased disorder throughout biological systems, can be quantified by homeostatic dysregulation (HD). One potential measure of HD is the dispersion of points from a normal value, approximated at the individual level by Mahalanobis distance (D). We hypothesized that greater HD in electrocardiogram (ECG) would also reflect greater HD in the musculoskeletal system which, in turn, would be associated with age and manifest as an increased risk of fracture independently of age, bone mineral density (BMD), and history of fracture.
View Article and Find Full Text PDFMed J Aust
September 2025
QIMR Berghofer, Brisbane, QLD.
Objective: To determine the cumulative incidence of overall and cause-specific mortality among Queensland residents admitted to hospital with cirrhosis during 2007-22, by cirrhosis aetiology.
Study Design: Retrospective cohort study; analysis of linked Queensland Hospital Admitted Patient Data Collection and Queensland Registry of Births, Deaths and Marriages data.
Setting, Participants: Adult Queensland residents (18 years or older) admitted to Queensland hospitals with cirrhosis during 1 July 2007 - 31 December 2022.